Assessing Quality of Life of Patients With Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

625

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

December 31, 2004

Study Completion Date

November 30, 2005

Conditions
Prostate Cancer
Interventions
OTHER

QoL assessment

qol questionnaires

Trial Locations (33)

1090

Academisch Ziekenhuis der Vrije Universiteit Brussel, Brussels

1200

Cliniques Universitaires Saint-Luc, Brussels

2100

Rigshospitalet, Copenhagen

3500

Virga Jesse Hospital, Hasselt

6009

Sir Charles Gairdner Hospital - Perth, Perth

10126

Azienda Sanitaria Ospedale San Giovanni Battista Molinette di Torino, Torino

20132

Istituto Scientifico H. San Raffaele, Milan

25124

Spedali Civili, Brescia

28100

Azienda Ospedaliera Maggiore Della Carita, Novara

35340

Dokuz Eylul University School of Medicine, Izmir

81190

Marmara University Hospital, Istanbul

86021

Hopital Jean Bernard, Poitiers

90141

Universita di Palermo, Palermo

B-9000

Universitair Ziekenhuis Gent, Ghent

B-8500

Cazk Groeninghe - Campus Maria's Voorzienigheid, Kortrijk

B-3000

U.Z. Gasthuisberg, Leuven

D-53105

Universitaetsklinikum Bonn, Bonn

D-20246

Universitaets-Krankenhaus Eppendorf, Hamburg

5211 NL

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch

1091 HA

Onze Lieve Vrouwe Gasthuis, Amsterdam

1105 AZ

Academisch Medisch Centrum, Amsterdam

6800 TA

Rijnstate Hospital, Arnhem

9713 GZ

Academisch Ziekenhuis Groningen, Groningen

NL-6500 HB

University Medical Center Nijmegen, Nijmegen

3000 CA

University Medical Center Rotterdam at Erasmus Medical Center, Rotterdam

3008 AE

Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam

5022 GC

St. Elisabeth Ziekenhuis, Tilburg

N-0310

Norwegian Radium Hospital, Oslo

RO 72435

Inselspital, Bern, Bucharest

Institute of Oncology - Bucarest, Bucharest

BS2 8ED

Bristol Haematology and Oncology Centre, Bristol

CF14 2TL

Velindre Cancer Center at Velinde Hospital, Cardiff

CF14 4XN

University of Wales College of Medicine, Cardiff

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00041301 - Assessing Quality of Life of Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter